Goldman Sachs M&A leader Michael Carr dies after neurodegenerative illness
Business
Michael Carr, a longtime leader in Goldman Sachs's mergers and acquisitions team, has died at 68.
His daughter Alexandra shared that he passed away on May 12 in Manhattan after facing a neurodegenerative disease.
Helped shape CVS Aetna $70B deal
Carr joined Goldman in 1998, a year before the firm went public. He helped shape some massive deals, like CVS buying Aetna for $70 billion and AbbVie's $63 billion Allergan takeover.
He also led the firm's advisory business across Asia outside Japan from 2000 to 2004, leaving a mark with his leadership and generosity.
Carr is survived by his wife Shelley, daughters Alexandra and Elisabeth, and sons-in-law.